BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29346334)

  • 21. [Changes of diagnosis and treatment for gastrointestinal stromal tumors during a 18-year period in four medical centers of China].
    Qiu H; Zhang P; Feng X; Chen T; Sun X; Yu J; Chen Z; Li Y; Tao K; Li G; Zhou Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1265-1270. PubMed ID: 27928797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
    Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
    Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subgroups of patients with very large gastrointestinal stromal tumors with distinct prognoses: a multicenter study.
    Wada N; Kurokawa Y; Nishida T; Takahashi T; Toyokawa T; Kusanagi H; Hirota S; Tsujinaka T; Mori M; Doki Y
    J Surg Oncol; 2014 Feb; 109(2):67-70. PubMed ID: 24155204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
    Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
    Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Which is the optimal risk stratification system for surgically treated localized primary GIST? Comparison of three contemporary prognostic criteria in 171 tumors and a proposal for a modified Armed Forces Institute of Pathology risk criteria.
    Goh BK; Chow PK; Yap WM; Kesavan SM; Song IC; Paul PG; Ooi BS; Chung YF; Wong WK
    Ann Surg Oncol; 2008 Aug; 15(8):2153-63. PubMed ID: 18546045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prognostic analysis of gastrointestinal stromal tumors complicated with gastrointestinal bleeding].
    Li RT; Zhang GJ; Fu WH; Li WD
    Zhonghua Zhong Liu Za Zhi; 2016 May; 38(5):377-80. PubMed ID: 27188612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physician Underestimation of the Risk of Gastrointestinal Stromal Tumor Recurrence After Resection.
    Guérin A; Sasane M; Keir CH; Gauthier G; Macalalad AR; Wu EQ; Conley AP
    JAMA Oncol; 2015 Sep; 1(6):797-805. PubMed ID: 26204106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of positive microscopic margins (R1 resection) in patients with GIST (gastrointestinal stromal tumours): Results of a multicenter European study.
    Thibaut F; Veziant J; Warlaumont M; Gauthier V; Lefèvre J; Gronnier C; Bonnet S; Mabrut JY; Regimbeau JM; Benhaim L; Tiberio GAM; Mathonnet M; Regenet N; Chirica M; Glehen O; Mariani P; Panis Y; Genser L; Mutter D; Théreaux J; Bergeat D; Le Roy B; Brigand C; Eveno C; Guillaume P;
    Eur J Surg Oncol; 2024 Jun; 50(6):108310. PubMed ID: 38598874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic role of gastrointestinal bleeding in patients with a primary gastrointestinal stromal tumor: a long-term follow-up study.
    Shi X; Chen Z; Shou C; Bai H; Yang W; Zhang Q; Liu X; Yu J
    J Gastrointest Oncol; 2023 Oct; 14(5):2028-2038. PubMed ID: 37969844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prognostic significance of clinicopathologic parameters in gastrointestinal stromal tumor: a study of 156 cases].
    Liang YM; Li XH; Lü YY; Lü YL; Zhong M; Pu XL; Li WM
    Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):233-8. PubMed ID: 17706113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastrointestinal stromal tumors (GIST) related emergencies.
    Sorour MA; Kassem MI; Ghazal Ael-H; El-Riwini MT; Abu Nasr A
    Int J Surg; 2014; 12(4):269-80. PubMed ID: 24530605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment.
    Ihle MA; Huss S; Jeske W; Hartmann W; Merkelbach-Bruse S; Schildhaus HU; Büttner R; Sihto H; Sundby Hall K; Eriksson M; Reichardt P; Joensuu H; Wardelmann E
    PLoS One; 2018; 13(2):e0193048. PubMed ID: 29451912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical pathological features and prognosis analysis of gastrointestinal stromal tumor: a series of 558 cases].
    Yang J; Yu J; Ma Z; Kang W; Tian S; Ye X
    Zhonghua Wai Ke Za Zhi; 2015 Apr; 53(4):274-9. PubMed ID: 26269161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low ETV1 mRNA expression is associated with recurrence in gastrointestinal stromal tumors.
    Sakamaki K; Funasaka K; Miyahara R; Furukawa K; Yamamura T; Ohno E; Nakamura M; Kawashima H; Hirooka Y; Fujishiro M; Goto H
    Sci Rep; 2020 Sep; 10(1):14767. PubMed ID: 32901065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival analysis of patients with duodenal gastrointestinal stromal tumors.
    Miki Y; Kurokawa Y; Hirao M; Fujitani K; Iwasa Y; Mano M; Nakamori S; Tsujinaka T
    J Clin Gastroenterol; 2010 Feb; 44(2):97-101. PubMed ID: 19809358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duodenal gastrointestinal stromal tumor: clinicopathological characteristics, surgical outcomes, long term survival and predictors for adverse outcomes.
    Yang F; Jin C; Du Z; Subedi S; Jiang Y; Li J; Di Y; Zhou Z; Tang F; Fu D
    Am J Surg; 2013 Sep; 206(3):360-7. PubMed ID: 23673012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate.
    Wu TJ; Lee LY; Yeh CN; Wu PY; Chao TC; Hwang TL; Jan YY; Chen MF
    BMC Gastroenterol; 2006 Oct; 6():29. PubMed ID: 17062131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Relevance of p53 Overexpression in Gastrointestinal Stromal Tumors of the Small Intestine: Potential Implication for Adjuvant Treatment with Imatinib.
    Yoo C; Koh YW; Park YS; Ryu MH; Ryoo BY; Park HJ; Yook JH; Kim BS; Kang YK
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S362-9. PubMed ID: 25791792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour - the impact of tumour rupture on patient outcomes.
    Rutkowski P; Bylina E; Wozniak A; Nowecki ZI; Osuch C; Matlok M; Switaj T; Michej W; Wroński M; Głuszek S; Kroc J; Nasierowska-Guttmejer A; Joensuu H
    Eur J Surg Oncol; 2011 Oct; 37(10):890-6. PubMed ID: 21737227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of gastric gastrointestinal stromal tumors in Shandong Province: a midterm report of multicenter GISSG1201 study].
    Hou Q; Luo W; Li L; Dai Y; Jiang L; Wang A; Chu X; Li Y; Yang D; Lu C; Yao L; Cui G; Lin H; Chen G; Cui Q; Zhang H; Lun Z; Xia L; Su Y; Han G; Hui X; Wei Z; Sun Z; Guo H; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1025-1030. PubMed ID: 28900994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.